New York, NY -- (SBWIRE) -- 12/12/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Dakota Plains Holdings Inc (OTCBB:DAKP), North American Palladium Ltd (USA) (NYSEMKT:PAL), Galena Biopharma Inc (NASDAQ:GALE), NVIDIA Corporation (NASDAQ:NVDA)
Dakota Plains Holdings Inc (OTCBB:DAKP) showed a volume of 757,680.00 shares by the end of last trade whereas the average volume of the stock remained 33,544.00 shares. The stock opened the session at $2.65 but then moved to $2.25. At that price, the stock showed a negative performance of -23.47%. Dakota Plains, Inc. engages in developing and owning transloading facilities to support the loading, marketing, and transporting of crude oil and related products from and into the North Dakota Williston Basin oil fields. The company was founded in 2008 and is based in Wayzata, Minnesota.
Will DAKP Get Buyers Even After The Recent Rally? Find Out Here
North American Palladium Ltd (USA) (NYSEMKT:PAL) opened the session at $0.49 and closed the session at $0.452. The stock showed a negative performance of -3.85% in previous trading session. Traded with volume of 2.88 million shares in the prior session and the average volume of the stock remained 2.28 million shares. North American Palladium Ltd. produces precious metals in Canada. It explores for palladium, platinum, nickel, gold, copper, and other metals. The company primarily holds interest in the Lac des Iles property that covers approximately 8,649 hectares of mineral claims and leases located northwest of the city of Thunder Bay, Ontario. The company was formerly known as Madeleine Mines Ltd. and changed its name to North American Palladium Ltd. in June 1993.
Has PAL Found The Bottom And Ready To Gain Momentum? Find Out Here
Galena Biopharma Inc (NASDAQ:GALE) opened the session at $3.79 and closed the session at $4.18. The stock showed a positive performance of 5.32% in previous trading session. Traded with volume of 7.80 million shares in the prior session and the average volume of the stock remained 5.86 million shares. The beta of the stock remained 1.10. Galena Biopharma, Inc. (Galena), formerly RXi Pharmaceuticals Corporation, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using targeted biotherapeutics. The Company is pursuing the development of cancer therapeutics using peptide-based immunotherapy products, including its main product candidate, NeuVaxTM (E75),
Why Should Investors Buy GALE After The Recent Gain? Just Go Here and Find Out
NVIDIA Corporation (NASDAQ:NVDA) the stock decreased -0.96% and finished the session at $15.41. Traded with volume of 10.35 million shares in the prior session and the average volume of the stock remained 8.45 million shares. The beta of the stock remained 1.36. NVIDIA Corporation (NVIDIA) is engaged in creating the graphics chips used in personal computers (PCs). The Company operates in three segments: graphics processing unit (GPU) Business, professional solutions business (PSB) and consumer products business (CPB). Its mobile processors are used in cell phones, tablets and auto infotainment systems.
Will NVDA Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)